Corcept Therapeutics
Clinical trials sponsored by Corcept Therapeutics, explained in plain language.
-
New hope for cushing syndrome: Long-Term drug safety trial underway
Disease control OngoingThis study looks at the long-term safety of a drug called relacorilant for people with Cushing syndrome, a condition where the body makes too much cortisol. About 125 adults who finished a previous relacorilant study and may benefit from more treatment will take the drug for up t…
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:57 UTC
-
New drug shows promise against fatty liver disease in Mid-Stage trial
Disease control OngoingThis study tests whether the drug miricorilant can safely reduce liver fat in adults with nonalcoholic steatohepatitis (NASH), a serious fatty liver disease. About 175 participants will receive either the drug or a placebo, and doctors will measure liver fat changes using MRI. Th…
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:33 UTC